| CCL4 |
CCL4, CCL4L, LAG1, MIP1B, SCYA4, SCYA4L: Small-inducible cytokine A4 precursor |
PTGIR |
PTGIR, PRIPR: Prostacyclin receptor |
0.632 |
Evidence |
|
| CCL4 |
CCL4, CCL4L, LAG1, MIP1B, SCYA4, SCYA4L: Small-inducible cytokine A4 precursor |
MC4R |
MC4R: Melanocortin receptor 4 |
0.632 |
Evidence |
|
| F5 |
F5: Coagulation factor V precursor |
EPHA7 |
EPHA7, EHK3, HEK11: Ephrin type-A receptor 7 precursor |
0.632 |
Evidence |
|
| F5 |
F5: Coagulation factor V precursor |
EPHA2 |
EPHA2, ECK: Ephrin type-A receptor 2 precursor |
0.632 |
Evidence |
|
| GHR |
GHR: Growth hormone receptor precursor |
IL2 |
IL2: Interleukin 2 |
0.632 |
Evidence |
|
| KIT |
KIT: Mast/stem cell growth factor receptor precursor |
SLA |
SLA, SLAP, SLAP1: SRC-like-adapter |
0.632 |
Evidence |
|
| PF4V1 |
PF4V1, SCYB4V1: Platelet factor 4 variant precursor |
LTB4R |
LTB4R, BLT, BLT1, BLTR, CMKRL1, GPR16, P2RY7: Leukotriene B4 receptor 1 |
0.632 |
Evidence |
|
| PF4V1 |
PF4V1, SCYB4V1: Platelet factor 4 variant precursor |
HTR6 |
HTR6: 5-hydroxytryptamine receptor 6 |
0.632 |
Evidence |
|
| PF4V1 |
PF4V1, SCYB4V1: Platelet factor 4 variant precursor |
SSTR3 |
SSTR3: Somatostatin receptor type 3 |
0.632 |
Evidence |
|
| IL8 |
IL8: Interleukin-8 precursor |
CXCR4 |
CXCR4: C-X-C chemokine receptor type 4 |
0.632 |
Evidence |
|
| IL8 |
IL8: Interleukin-8 precursor |
HTR6 |
HTR6: 5-hydroxytryptamine receptor 6 |
0.632 |
Evidence |
|
| IL8 |
IL8: Interleukin-8 precursor |
TRHR |
TRHR: Thyrotropin-releasing hormone receptor |
0.632 |
Evidence |
|
| IL8 |
IL8: Interleukin-8 precursor |
IL8RB |
IL8RB, CXCR2: High affinity interleukin-8 receptor B |
0.632 |
Evidence |
|
| PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
SH2D2A |
SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A |
0.632 |
Evidence |
|
| CXCL1 |
CXCL1, GRO, GRO1, GROA, MGSA, SCYB1: Growth-regulated protein alpha precursor |
CCR5 |
CCR5: CCR5 receptor (Fragment) |
0.632 |
Evidence |
|
| CXCL1 |
CXCL1, GRO, GRO1, GROA, MGSA, SCYB1: Growth-regulated protein alpha precursor |
P2RY4 |
P2RY4, NRU: P2Y purinoceptor 4 |
0.632 |
Evidence |
|
| CXCL1 |
CXCL1, GRO, GRO1, GROA, MGSA, SCYB1: Growth-regulated protein alpha precursor |
PTGIR |
PTGIR, PRIPR: Prostacyclin receptor |
0.632 |
Evidence |
|
| CXCL1 |
CXCL1, GRO, GRO1, GROA, MGSA, SCYB1: Growth-regulated protein alpha precursor |
SSTR3 |
SSTR3: Somatostatin receptor type 3 |
0.632 |
Evidence |
|
| CXCL1 |
CXCL1, GRO, GRO1, GROA, MGSA, SCYB1: Growth-regulated protein alpha precursor |
MC4R |
MC4R: Melanocortin receptor 4 |
0.632 |
Evidence |
|
| CXCL1 |
CXCL1, GRO, GRO1, GROA, MGSA, SCYB1: Growth-regulated protein alpha precursor |
FPRL1 |
FPRL1, FPR2, FPRH1, LXA4R: FMLP-related receptor I |
0.632 |
Evidence |
|
| IL3 |
IL3: Interleukin-3 precursor |
IL9R |
IL9R: Interleukin-9 receptor precursor |
0.632 |
Evidence |
|
| IL3 |
IL3: Interleukin-3 precursor |
EPOR |
EPOR: Erythropoietin receptor precursor |
0.632 |
Evidence |
|
| SERPINF2 |
SERPINF2, AAP, PLI: Alpha-2-antiplasmin precursor |
ST14 |
ST14, PRSS14, SNC19, TADG15: Suppressor of tumorigenicity protein 14 |
0.632 |
Evidence |
|
| MET |
MET: Hepatocyte growth factor receptor precursor |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
0.632 |
Evidence |
|
| MET |
MET: Hepatocyte growth factor receptor precursor |
RIN1 |
RIN1: Ras and Rab interactor 1 |
0.632 |
Evidence |
|